MAPT and frontotemporal dementia: The effect of the MAPT c.855C>T (p.Asp285Asp) change on levels of τp-181 in the FTD/ALS cohort we studied suggests that this variant could be an indirect modifier of tau phosphorylation (e.g., by affecting mRNA processing) and thus of pathophysiological significance.